| Literature DB >> 24858094 |
Vanessa Mara Chapla1, Maria Luiza Zeraik2, Valdecir F Ximenes3, Lisinéia Maria Zanardi4, Márcia N Lopes5, Alberto José Cavalheiro6, Dulce Helena S Silva7, Maria Cláudia M Young8, Luiz Marcos da Fonseca9, Vanderlan S Bolzani10, Angela Regina Araújo11.
Abstract
Chemical investigation of an acetonitrile fraction from the endophytic fungus Phomopsis sp. led to the isolation of the new natural product 2-hydroxy-alternariol (7) together with the known compounds cytochalasins J (1) and H (2), 5'-epialtenuene (3) and the mycotoxins alternariol monomethyl ether (AME, 4), alternariol (AOH, 5) and cytosporone C (6). The structure of the new compound was elucidated by using 1-D and 2-D NMR (nuclear magnetic resonance) and high resolution mass spectrometry. The cytochalasins J (1) and H (2) and AOH (5) exhibited potent inhibition of the total ROS (reactive oxygen species) produced by stimulated human neutrophils and acted as potent potential anti-inflammatory agents. Moreover, cytochalasin H (2) demonstrated antifungal and acetylcholinesterase enzyme (AChE) inhibition in vitro.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24858094 PMCID: PMC6271730 DOI: 10.3390/molecules19056597
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chemical structures of 1–7 produced by Phomopsis sp.
.1H (500 MHz) and 13C-NMR (125 MHz) spectral data for 7 in DMSO-d.
| 7 | ||
|---|---|---|
| Position |
| |
| 1 | - | 122.0 |
| 2 | - | 141.7 |
| 3 | - | 146.5 |
| 4 | 6.68 (
| 100.7 |
| 5 | - | * |
| 6 | - |
|
| 6a | - | 97.4 |
| 7 | - | 164.4 |
| 8 | 6.34 (
| 100.5 |
| 9 | - | 165.0 |
| 10 | 7.26 (
| 104.1 |
| 10a | - |
|
| 10b | - | 109.0 |
| 1-CH3 | 2.58 (
| 18.8 |
* not detected.
Figure 2Key HMBC (→) and NOESY (↔) correlations for 2-hydroxy-alternariol (7).
Figure 3The ability of the tested compounds and standards to inhibit the total ROS produced by stimulated neutrophils.
Evaluation of the cytotoxicity of compounds 1, 2, 4 and 5 at different times and concentrations.
| Compounds | Concentration (µmol L−1) | Viable cells (%) * | |
|---|---|---|---|
| 30 min | 60 min | ||
| Control | 99.0 ± 0.60 | 99.0 ± 1.41 | |
| 1 | 100 | 80.0 ± 2.80 | 50.0 ± 2.80 |
| 1 | 10 | 97.0 ± 0.70 | 97.0 ± 0.70 |
| 2 | 100 | 85.0 ± 1.40 | 60.0 ± 2.80 |
| 2 | 10 | 96.0 ± 0.70 | 96.0 ± 1.41 |
| 4 | 100 | 85.0 ± 3.50 | 50.0 ± 2.80 |
| 4 | 10 | 95.0 ± 1.41 | 95.0 ± 0.70 |
| 5 | 100 | 70.0 ± 2.80 | 45.0 ± 2.80 |
| 5 | 10 | 96.0 ± 0.70 | 96.0 ± 0.70 |
* The data are expressed as the means ± the standard deviation; n = 3. Each compound was assayed in triplicate.